journal
MENU ▼
Read by QxMD icon Read
search

Netherlands Heart Journal

journal
https://www.readbyqxmd.com/read/29974355/2017-esc-guidelines-for-the-management-of-acute-myocardial-infarction-in-patients-presenting-with-st-segment-elevation-comments-from-the-dutch-acs-working-group
#1
F Arslan, L Bongartz, J M Ten Berg, J W Jukema, Y Appelman, A H Liem, R J de Winter, A W J van 't Hof, P Damman
On behalf of the Dutch ACS working group, we discuss the most important changes in recommendations in the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation relevant for both the general and interventional cardiologist.
July 4, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29946964/what-is-the-cause-of-p-wave-undersensing-in-this-crt-d-device
#2
J Schroemges, F A L E Bracke, B M van Gelder
No abstract text is available yet for this article.
June 26, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29943117/trends-in-patient-characteristics-and-clinical-outcome-over-8-years-of-transcatheter-aortic-valve-implantation
#3
F van Kesteren, M S van Mourik, E M A Wiegerinck, J Vendrik, J J Piek, J G Tijssen, K T Koch, J P S Henriques, J J Wykrzykowska, R J de Winter, A H G Driessen, A Kaya, R N Planken, M M Vis, J Baan
AIM: In the evolving field of transcatheter aortic valve implantations (TAVI) we aimed to gain insight into trends in patient and procedural characteristics as well as clinical outcome over an 8‑year period in a real-world TAVI population. METHODS: We performed a single-centre retrospective analysis of 1,011 consecutive patients in a prospectively acquired database. We divided the cohort into tertiles of 337 patients; first interval: January 2009-March 2013, second interval: March 2013-March 2015, third interval: March 2015-October 2016...
June 25, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29943116/coronary-pressure-derived-parameters
#4
EDITORIAL
J J Piek
No abstract text is available yet for this article.
June 25, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29943115/transcatheter-aortic-valve-replacement-with-the-34-mm-medtronic-evolut-valve-early-results-of-single-institution-experience
#5
G D'Ancona, M Dißmann, H Heinze, D Zohlnhöfer-Momm, H Ince, S Kische
OBJECTIVES: To report our experience with the recently introduced 34 mm Evolut transcatheter aortic valve replacement (TAVR) prosthesis. BACKGROUND: A larger TAVR prosthesis has become available for the treatment of aortic stenosis (AVS) in larger native aortic annuli (up to 30 mm). Outcomes with this new device are still unreported. RESULTS: The first 25 transfemoral TAVRs performed by our team with the self-expandable 34 mm Evolut are presented...
June 25, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29943114/what-is-the-cause-of-p%C3%A2-wave-undersensing-in-this-crt-d-device
#6
J Schroemges, F A L E Bracke, B M van Gelder
No abstract text is available yet for this article.
June 25, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29934837/treating-patients-suffering-from-acute-coronary-syndrome-with-prasugrel-the-rotterdam-experience
#7
EDITORIAL
R J de Winter
No abstract text is available yet for this article.
June 21, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29931649/one-year-efficacy-and-safety-of-routine-prasugrel-in-patients-with-acute-coronary-syndromes-treated-with-percutaneous-coronary-intervention-results-of-the-prospective-rijnmond-collective-cardiology-research-study
#8
T Yetgin, E Boersma, P C Smits, A G de Vries, E Huijskens, F Zijlstra, M M J M van der Linden, R J M van Geuns
OBJECTIVE: To investigate 1‑year outcomes with routine prasugrel treatment after acute coronary syndrome (ACS) in a large-scale registry. METHODS: The Rijnmond Collective Cardiology Research registry is a prospective, observational study that enrolled 4,258 consecutive ACS patients treated with percutaneous coronary intervention (PCI) with 1‑year follow-up. Patients received prasugrel as first-choice antiplatelet agent, except for increased bleeding risk patients in which clopidogrel was recommended...
June 21, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29923057/instantaneous-wave-free-ratio-and-fractional-flow-reserve-in-clinical-practice
#9
R Pisters, M Ilhan, L F Veenstra, B C G Gho, M Stein, J C A Hoorntje, S Rasoul
OBJECTIVES: To compare fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) measurements in an all-comer patient population with moderate coronary artery stenoses. BACKGROUND: Visual assessment of the severity of coronary artery stenoses is often discordant in moderate lesions. FFR allows reliable functional severity assessment in these cases but requires adenosine-induced hyperaemia with associated additional time, costs and side effects. The iFR is a hyperaemia-independent index...
June 19, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29882041/competence-of-general-practitioners-in-requesting-and-interpreting-ecgs-a-case-vignette-study
#10
S A M Compiet, R T A Willemsen, K T S Konings, H E J H Stoffers
BACKGROUND: Performing electrocardiography is common in general practice, but the quality of indication setting and diagnostic accuracy have been disputed. OBJECTIVES: To assess the competence of general practitioners (GPs) in their decision-making process with regard to recording and interpreting an electrocardiogram (ECG) and evaluating the relevance of the result for management. METHODS: An online case vignette survey was performed among GPs and cardiologists (in 2015)...
June 7, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29882040/life-long-tailoring-of-diagnosis-and-management-of-patients-with-idiopathic-ventricular-fibrillation-future-perspectives-in-research
#11
REVIEW
L J Blom, P G A Volders, A A Wilde, R J Hassink
The diagnosis and management of idiopathic ventricular fibrillation is challenging, as it requires extensive diagnostic testing and offers few curative options due to unknown underlying disease. The resulting population is a heterogeneous group of patients with a largely unknown natural history. Structural patient characterisation, follow-up and innovations in diagnostic testing can improve our understanding of the disease mechanisms of idiopathic ventricular fibrillation, detect underlying disease during follow-up and aid in therapeutic management...
June 7, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29744816/periprocedural-anticoagulation-in-atrial-fibrillation-update-on-electrical-cardioversion-and-ablation
#12
REVIEW
S P G van Vugt, M A Brouwer
In this manuscript, we discuss the most important changes in the field of anticoagulant treatment in patients with atrial fibrillation in the setting of electrical cardioversion or catheter ablation. Moreover, we provide practical guidance as well as information on daily practice.
May 9, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29740755/optimal-antithrombotic-treatment-of-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention-triple-therapy-is-too-much
#13
REVIEW
M S Jacobs, R G Tieleman
Patients with atrial fibrillation who undergo a coronary intervention are eligible for both anticoagulation and (dual) antiplatelet therapy ((D)APT). An optimal balance has to be found to reduce the thromboembolic risk (i.e. stroke, systemic embolism and myocardial infarction) and to minimise the increased risk of bleeding with concomitant use of an anticoagulant and (D)APT. Owing to a lack of evidence, the guideline recommendations are predominantly based on expert opinion. Current evidence indicates that the combination of a non-vitamin K oral anticoagulant (NOAC) and clopidogrel is safer than vitamin-K oral antagonists plus DAPT, which increases the risk of bleeding, without clear advantages in regard to efficacy...
May 8, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29740754/a-practical-guide-on-how-to-handle-patients-with-bleeding-events-while-on-oral-antithrombotic-treatment
#14
REVIEW
M E Gimbel, S C S Minderhoud, J M Ten Berg
Bleeding is a feared complication in patients who are treated with antithrombotic therapy (oral anticoagulation or antiplatelet therapy). Management of antithrombotic therapy after bleeding poses a dilemma where restarting the crucial medication could lead to recurrent bleeding, while interrupting or even discontinuing treatment could increase the thrombotic risk. In this review, we provide recommendations regarding the treatment of patients with a bleeding event while on oral antithrombotic therapy, based on the literature and expert opinion...
May 8, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29722003/optimal-long-term-antithrombotic-management-of-atrial-fibrillation-life-cycle-management
#15
REVIEW
R Pisters, A Elvan, H J G M Crijns, M E W Hemels
Optimal antithrombotic management of atrial fibrillation equals balancing between prevention of arterial thromboembolism, predominantly ischaemic stroke, and haemorrhagic complications. Over time different antithrombotic agents and strategies have been developed. At present, non-vitamin K antagonist oral anticoagulants (NOACs) are the first-line therapy for stroke prevention in patients with non-valvular atrial fibrillation (i.e. without a mechanical valve prosthesis or rheumatic heart disease). Considering the impact of the suboptimal adoption of recommended oral anticoagulant therapy, as experienced with the previous first-line vitamin K antagonists, this review focuses on adequate use of NOACs...
May 2, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29797236/anticoagulation-and-antiplatelet-therapy-in-acute-coronary-syndromes-choosing-between-the-scylla-of-bleeding-and-the-charybdis-of-ischaemic-events
#16
EDITORIAL
R J de Winter
No abstract text is available yet for this article.
June 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29713990/optimal-treatment-of-patients-with-nste-acs-in-the-dutch-health-care-system
#17
REVIEW
J P van Kuijk, J M Ten Berg
In the current daily practice of acute coronary syndromes, patients experiencing non-ST-elevation acute coronary syndrome (NSTE-ACS) represent the majority of this population. In these patients it is of utmost importance to estimate both ischaemic and bleeding risk, with subsequent, and preferably tailored pharmacological and, if indicated, invasive treatment. In this paper we describe the several risk scores and evaluate which are most applicable to the Dutch health-care system. Furthermore, we provide an overview of the recommended pharmacological treatment in keeping with the European Society of Cardiology guidelines...
June 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29713989/optimal-duration-of-dual-antiplatelet-therapy-for-coronary-artery-disease
#18
REVIEW
W J Kikkert, P Damman
The optimal duration of dual antiplatelet therapy (DAPT) for stable coronary artery disease and acute coronary syndrome is a complex decision. We review current literature on standard duration DAPT versus short duration DAPT (6 months or shorter) or extended duration DAPT (>12 months) after percutaneous coronary intervention with drug-eluting stent placement, and prolonged treatment after 12 months in acute coronary syndrome. Current guideline recommendations are summarised, including the use of risk scores for ischaemic and bleeding risk assessment...
June 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29687412/optimal-pharmacological-therapy-in-st-elevation-myocardial-infarction-a-review-a-review-of-antithrombotic-therapies-in-stemi
#19
REVIEW
R S Hermanides, S Kilic, A W J van 't Hof
Antithrombotic therapy is an essential component in the optimisation of clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. There are currently several intravenous anticoagulant drugs available for primary percutaneous coronary intervention. Dual antiplatelet therapy comprising aspirin and P2Y12 inhibitor represents the cornerstone treatment for STEMI. However, these effective treatment strategies may be associated with bleeding complications...
June 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29667076/cough-up-your-lungs
#20
L A J Rammeloo, N A Blom
No abstract text is available yet for this article.
June 2018: Netherlands Heart Journal
journal
journal
39609
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"